Yale researchers are developing a skin cancer treatment that involves injecting nanoparticles into the tumor, killing cancer cells with a two-pronged approach, as a potential alternative to surgery.

The results are published in the Proceedings of the National Academy of Sciences. “For a lot of patients, treating skin cancer is much more involved than it would be if there was a way to effectively treat them with a simple procedure like an injection,” said Dr. Michael Girardi, professor and vice chair of dermatology at Yale School of Medicine and senior author of the study...

Scientists and engineers at the University of Sydney and Microsoft Corporation have opened the next chapter in quantum technology with the invention of a single chip that can generate control signals for thousands of qubits, the building blocks of quantum computers.

“To realise the potential of quantum computing, machines will need to operate thousands if not millions of qubits,” said Professor David Reilly, a designer of the chip who holds a joint position with Microsoft and the University of Sydney.

“The world’s biggest quantum computers currently operate with just 50 o...

Shedding light on the evolution of the Universe. The complex mechanics determining how galaxies spin, grow, cluster and die have been revealed following the release of all the data gathered during a massive seven-year Australian-led astronomy research project.

The scientists observed 13 galaxies at a time, building to a total of 3068, using a custom-built instrument called the Sydney-AAO Multi-Object Integral-Field Spectrograph (SAMI), connected to the 4-metre Anglo-Australian Telescope (AAT) at Siding Spring Observatory in New South Wales. The telescope is operated by the Australian National University.

Overseen by ...

Taking a particular type of medication to treat enlarged prostate is associated with a reduced risk of developing Parkinson’s disease, according to a large observational study led by researchers at the University of Iowa, with colleagues in Denmark and China.

The findings, published Feb. 1 in JAMA Neurology, provide compelling evidence that terazosin, and similar medications, might have the potential to prevent or delay the development of Parkinson’s disease.

The new study used data on almost 300,000 older men from two large, independent patient datasets — the Truven Health Analytics MarketScan database in the Uni...